THE ORAL AND DENTAL RESEARCH TRUST

Registered charity 800234 · accounts filings on the Charity Commission register

Support Oral and Dental Research activity through small grant programmes and occasional seminars

Causes: Education/training · The Advancement Of Health Or Saving Of Lives · website · Get email alerts

Latest income
£58k
Latest spending
£60k
Registered
1988
Accounts read
FY2025

Financial health, per its FY2025 accounts

The accounts state that the charity reported a surplus of £1,757 for the year ended 31 March 2025, with total unrestricted funds carried forward amounting to £165,244. The trustees note that the low level of running costs has been maintained, and the charity remains dependent on sponsor support which amounted to £53,000. There are no stated reserves policy targets or material uncertainties regarding the charity's ability to continue its activities.

Automated summary of the FY2025 accounts; the evidenced findings below carry the verbatim passages.

What the accounts disclose

Accounts independently examined (not a full audit). Discloses 4 of 6 completeness components.

Public profiles (found on the charity’s own website): facebook

Trustees · trustee networks

Trustee list from the Charity Commission register (current, not historical).

Operates in: Northern Ireland · Scotland · Throughout England And Wales

Income and spending

Financial year endIncomeSpending
31/03/2025£58k£60k
31/03/2024£52k£58k
31/03/2023£52k£61k
31/03/2022£78k£61k
31/03/2021£45k£51k

Common questions

Is THE ORAL AND DENTAL RESEARCH TRUST financially healthy?

Per its FY2025 accounts: The accounts state that the charity reported a surplus of £1,757 for the year ended 31 March 2025, with total unrestricted funds carried forward amounting to £165,244. The trustees note that the low level of running costs has been maintained, and the charity remains dependent on sponsor support which amounted to £53,000. There are no stated reserves policy targets or material uncertainties regarding the charity's ability to continue its activities. Its FY2025 accounts were independently examined.